This study evaluated a simplified intravenous fluid (IVF) approach for pediatric diabetic ketoacidosis (DKA) that applies a single, fixed rehydration rate to all patients. The intent was to test whether a standardized fluid administration rate could achieve outcomes comparable to guideline-based individualized regimens while avoiding the need for routine calculations of fluid deficit or maintenance requirements.
The analysis included data from 252 pediatric patients diagnosed with DKA. The cohort was divided evenly: 126 patients received the modified fixed-rate IVF protocol and 126 were treated according to the International Society for Paediatric and Adolescent Diabetes (ISPAD) IVF regimen. The report is presented as an abstract; therefore, detailed enrollment criteria, randomization or allocation methods, and baseline characteristic distributions are not reported in this source.
Under the modified protocol, every patient received rehydration fluid at a standard rate of 3000 mL/m²/24 h. This infusion rate was held constant and was not adjusted based on dehydration severity, patient age, initial blood glucose level, calculated daily fluid deficit, or standard maintenance fluid calculations. The abstract emphasizes that this simplified approach removes the need for individualized fluid-deficit or maintenance determinations during DKA management for eligible pediatric patients.
The comparator arm followed the International Society for Paediatric and Adolescent Diabetes (ISPAD) IVF regimen. Specific ISPAD dosing details, adjustments, and implementation steps used in the comparator group are not provided in the abstract. The study compares clinical outcomes between the uniform fixed-rate strategy and the ISPAD-based individualized regimen.
The primary outcome reported in the abstract was time to resolution of acidosis. Median acidosis recovery time was reported as 9 hours in both treatment groups, with ranges of 2–46 hours in the modified-protocol group and 2–34 hours in the ISPAD group. The between-group difference was not statistically significant (P = .48). The abstract does not list additional secondary efficacy endpoints or provide laboratory or physiologic trajectories beyond the acidosis recovery metric.
According to the abstract, there were no statistically significant differences between the groups in terms of treatment-related problems. The authors report that the modified IVF protocol did not increase adverse events compared with the ISPAD regimen within the population studied. The abstract does not supply granular safety data, rates of specific complications, or criteria used to define treatment-related problems.
The authors conclude that the modified fixed-rate IVF protocol—3000 mL/m²/24 h delivered without individualized deficit or maintenance calculations—can be used safely and effectively in pediatric patients with DKA who do not require immediate intensive care unit management. The reported advantages are procedural simplicity and elimination of routine fluid-deficit and maintenance calculations, while achieving comparable acidosis recovery times and no increase in reported treatment-related problems versus the ISPAD regimen.
The abstract omits several methodological and outcome details that would be needed for full appraisal and implementation guidance. Specifically, the source does not report randomization methods or whether allocation was prospective, baseline demographic and clinical characteristics by group, precise definitions for acidosis recovery and treatment-related problems, rates of specific adverse events, or outcomes in subgroups such as different dehydration severities or ages. Additionally, the authors note that the approach is not intended for patients who require initial intensive care unit-level management; criteria used to define that exclusion are not provided in the abstract.
From the data presented in this abstract, a standardized rehydration rate of 3000 mL/m²/24 h produced similar median acidosis recovery time and similar reported safety outcomes compared with an ISPAD-based IVF regimen in a cohort of 252 pediatric DKA patients. The modified protocol may simplify bedside calculations and reduce complexity in settings where patients do not require ICU-level care. Clinicians should consult the full manuscript for detailed methods, safety metrics, and subgroup analyses before changing practice, as those details were not included in the abstract.